MiR-4728-3p could act as a marker of HER2 status-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

MiR-4728-3p could act as a marker of HER2 status

Published:2015-11-24 Issue:6 Volume:15 Page:807-814
ISSN:1574-0153
Container-title:Cancer Biomarkers
language:
Short-container-title:CBM

Author:

Li Hai¹,Zhou Xin²,Zhu Jun³,Cheng Wenfang⁴,Zhu Wei²,Shu Yongqian²,Liu Ping²

Affiliation:

1. Department of Pathology, First Affiliated Hospital of Nanjing Medical University, Nanjing, Jiangsu, China

2. Department of Oncology, First Affiliated Hospital of Nanjing Medical University, Nanjing, Jiangsu, China

3. Department of Radiation Oncology, Jiangsu Cancer Hospital, Nanjing, Jiangsu, China

4. Department of Gastroenterology, First Affiliated Hospital of Nanjing Medical University, Nanjing, Jiangsu, China

Publisher

IOS Press

Subject

Cancer Research,Genetics,Oncology,General Medicine

Cited by 18 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Resistance of HER2-expressing ovarian cancer to trastuzumab and mechanisms of overcoming resistance;Overcoming Cancers Resistant to HER-2 Antibodies;2024

2. Methods and biomarkers for early detection, prediction, and diagnosis of colorectal cancer;Biomedicine & Pharmacotherapy;2023-07

3. Mir-4728 is a Valuable Biomarker for Diagnostic and Prognostic Assessment of HER2-Positive Breast Cancer;Frontiers in Molecular Biosciences;2022-05-17

4. miR-485-3p and miR-4728-5p as Tumor Suppressors in Pathogenesis of Colorectal Cancer;Molecular Biology;2022-03-02

5. Three plasma-based microRNAs as potent diagnostic biomarkers for endometrial cancer;Cancer Biomarkers;2021-06-18

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP